BRIAN SO: Open Payments
NPI 1841499100 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,131 in 130 payments from 15 companies in 2025. Trend: 2023 $9,997 · 2024 $2,409 · 2025 $2,131
Food & beverage: $2,131
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $552 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $318 |
| Janssen Biotech, Inc. | 10 | $207 |
| Ardelyx, Inc. | 11 | $207 |
| PFIZER INC. | 15 | $188 |
| Phathom Pharmaceuticals, Inc. | 7 | $128 |
| Madrigal Pharmaceuticals | 5 | $116 |
| GENZYME CORPORATION | 5 | $112 |
| Lilly USA, LLC | 5 | $99 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $82 |
Products named: ENTYVIO, TREMFYA, IBSRELA, SKYRIZI, RINVOQ, VOQUEZNA, REZDIFFRA, XELJANZ.
Industry payments across TX — which companies pay providers there.
